Radiolabeled Antibody Therapy Of B Cell Lymphoma With Autologous Bone Marrow Support

Searching for Radiolabeled Antibody Therapy Of B Cell Lymphoma With Autologous Bone Marrow Support information? Find all needed info by using official links provided below.


Radiolabeled-Antibody Therapy of B-Cell Lymphoma with ...

    https://www.nejm.org/doi/full/10.1056/NEJM199310213291702
    Original Article from The New England Journal of Medicine — Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportCited by: 993

Myeloablative Radiolabeled Antibody Therapy with ...

    https://link.springer.com/chapter/10.1007/978-1-4615-2013-9_13
    Press OW, Eary J, Appelbaum F, et al.: Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 329:1219, 1993. PubMed CrossRef Google ScholarCited by: 7

Biodistribution and Dosimetry of 177Lu-tetulomab, a New ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624777/
    Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl.Cited by: 23

Monoclonal antibodies and autologous stem cell ...

    https://www.nature.com/articles/1702857
    Apr 23, 2001 · Autologous marrow grafts from 114 B cell malignancy patients were purged in vitro with a cocktail of anti-B cell monoclonal antibodies (anti-B1, anti-B5, anti-J5). The efficacy of the marrow ...Cited by: 14

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral ...

    https://clinicaltrials.gov/ct/show/NCT00004107
    DISEASE CHARACTERISTICS: Histologically or cytologically proven B cell lymphoma of one of the following types: Any histologic grade of non-Hodgkin's lymphoma Chronic lymphocytic leukemia CD22 positive acute lymphocytic leukemia Waldenstrom's macroglobulinemia Must have failed at least 1 standard therapy Autologous peripheral blood stem cells (PBSC) or bone marrow available Bone marrow ...

High‐dose myeloablative radioimmunotherapy of mantle cell ...

    https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.10307
    High‐dose myeloablative radioimmunotherapy of mantle cell non‐hodgkin lymphoma with the iodine‐131–labeled chimeric anti‐CD20 antibody C2B8 and autologous stem cell support. [THIS ARTICLE HAS BEEN RETRACTED] Results of a pilot studyCited by: 100

Radioimmunotherapy: A New Treatment Modality for B-Cell ...

    https://www.cancernetwork.com/leukemia-lymphoma/radioimmunotherapy-new-treatment-modality-b-cell-non-hodgkins-lymphoma/page/0/1
    Aug 25, 2019 · Goldenberg DM: The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: The coming of age of radioimmunotherapy. Crit Rev Oncol Hematol 39:195-201, 2001. 36. Sharkey RM, Behr TM, Mattes MJ, et al: Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22. Cancer ImmunolCited by: 13



How to find Radiolabeled Antibody Therapy Of B Cell Lymphoma With Autologous Bone Marrow Support information?

Follow the instuctions below:

  • Choose an official link provided above.
  • Click on it.
  • Find company email address & contact them via email
  • Find company phone & make a call.
  • Find company address & visit their office.

Related Companies Support